CDS: A Solution for mRNA Vaccine Damage
By: Dr.h.c. Andreas Ludwig Kalcker (review by Dr. Atilio Cavezzi )
Chlorine Dioxide as a Solution for mRNA Vaccine Damage: A Critical Perspective
As the world grapples with the aftermath of the COVID-19 pandemic, the swift development and deployment of mRNA vaccines have been both a scientific triumph and a subject of scrutiny. While these vaccines may have played a role in controlling the severity of the disease in critically ill patients (e.g. elderly with multiple diseases) , their long-term effects remain inadequately studied, raising concerns about potential adverse reactions. In this context, chlorine dioxide (CDS) emerges as a viable therapeutic option, offering relief from some of the most concerning side effects associated with mRNA vaccines.
Concerns with mRNA Vaccines
The advent of mRNA vaccines was initially heralded as a revolutionary advancement in the field of immunization, promising to enhance public health outcomes through expedited development and deployment strategies. However, the accelerated pace at which these vaccines were introduced has precipitated significant scrutiny regarding their long-term safety profile. This has led to a substantial number of adverse events being reported, which has generated considerable apprehension among both healthcare professionals and the general public.
Of particular concern is the incidence of myocarditis, a condition characterized by inflammation of the myocardium (heart muscle), which has been predominantly observed in younger demographics following vaccination. Additionally, there has been an uptick in cases of Guillain-Barré Syndrome and Bell's Palsy, raising further safety considerations. Reports of cerebrovascular accidents (strokes) and the emergence of rapidly progressing malignancies, colloquially termed "turbo cancer," have also surfaced in some individuals post-vaccination, alongside instances of sudden unexpected deaths.
These observations necessitate a rigorous and comprehensive evaluation of the risk-benefit ratio associated with mRNA vaccines, underscoring the imperative for ongoing monitoring and research to elucidate potential causal relationships and to ensure the optimization of vaccine safety.
Chlorine Dioxide: A Potential Remedy but why ?
In light of these concerns, chlorine dioxide presents a solution. As detailed in recent studies, regarding our studies [ Link ] CDS possesses potent oxidative properties capable of neutralizing harmful spike proteins by oxidation and reducing inflammation oxidising Histamine.
Chlorine dioxide (CDS) is gaining attention in the medical field due to its exceptional oxido-reductive properties, which are primarily driven by its electron transfer capabilities and high oxidation-reduction potential (ORP). These characteristics enable CDS to neutralize harmful proteins and mitigate inflammation effectively.
- Electron Transfer Mechanism: The core of CDS's therapeutic action in infections, as well as in post-COVID vaccine adverse effects, lies in its ability to act as a potent oxidizing agent. It achieves this by accepting electrons from other molecules, such as pathogens or dysfunctional proteins. This electron transfer process leads to the selective oxidation of these target molecules, resulting in their structural modification or inactivation. This capability is crucial for disrupting the integrity of harmful entities within the body, thereby reducing their pathogenic potential.
- High Oxidation-Reduction Potential (ORP): CDS's high ORP signifies its strong oxidative and reduction capacity. A high ORP enables CDS to efficiently oxidate harmful molecules/compounds/organisms. In biological contexts, this means effectively breaking down electron-rich structures in pathogens or harmful proteins, neutralizing them and reducing their impact on the organism. Conversely, CDS acts as an antioxidant (reductive) agent against harmful OH or O- radicals, being reduced to H2O (water) or O2 (oxygen). This ability makes CDS an extremely important discovery in medicine of the past 100 years.
- Biochemical Impact on Inflammation: One of the key mediators of inflammation is histamine, whose elevated levels can exacerbate inflammatory responses. Through its oxidative action, CDS can oxidize histamine, effectively reducing its bioavailability and activity. This reduction in histamine levels is essential for alleviating any form inflammation, including symptoms such as swelling and itching, which are common in allergic and autoimmune conditions.
COVID-19 vaccine leads immune cells to produce spike proteins, which in turn may facilitate a number of potential pathophysiology systemic and/or local changes in the human organism. CDS works by oxidizing crucial amino acids in spike proteins, such as cysteine and tyrosine, denaturing the spike protein created by the genetic alteration caused by mRNA in the epithelial cells of the inoculated person, which help mitigate inflammatory responses such as myocarditis. Its ability to reduce oxidative stress suggests it could play a crucial role in addressing vascular issues like strokes by restoring cellular equilibrium disrupted by vaccine components.
More specifically, it was proven COVID-19 vaccine may induce the following main pathophysiology changes in the receiving individual:
a) an altered immunity with systemic inflammation,
b) dysfunctional mitochondria,
c) alteration in the autonomic nervous system, as part of the small fiber nerve disease,
d) dysregulation in the histamine production/reabsorption system,
e) coagulation abnormalities. These potential alterations may take place more or less frequently based on the individual conditions and on other technical issues, as detailed by a few papers [ link ]
Additionally, the systemic effects of chlorine dioxide may provide protection against the swift growth of cancer cells following vaccination. In fact, by decreasing lactic acid, the primary metabolite of cancer, and reducing oxidative stress while modulating immune responses, it might potentially block the pathways responsible for aggressive cancer development.
Clinical Observations and Future Directions
Observational studies in Latin America of the COMUSAV association with a great number of medical doctors have showcased the efficacy of chlorine dioxide in treating hundred thousand COVID-19 patients, providing a foundation for its application in managing vaccine-related side effects. These findings underscore the need for clinical trials to explore its potential fully.
The rapid action of CDS is particularly advantageous for managing both acute adverse reactions and long-term adverse effects from COVID_19 vaccination, offering a timely intervention to mitigate symptoms and restore health.
How can we diagnose vaccine damage ?
In individuals, particularly those who are young and actively engaged in physical activities, it can be challenging to detect underlying pathologies that may not manifest with overt clinical symptoms. To preemptively identify potential health risks that could precipitate severe consequences, it is prudent to conduct a comprehensive analysis of specific biomarkers.
Several biomarkers proved to highlight immune deregulation, chronic inflammation, mitochondria dysfunction, histamine hyperactivity etc. Two critical indicators in this context are D-Dimer and ferritin levels.
D-Dimer is a fibrin degradation product, and elevated levels may indicate abnormal clotting activity, which could suggest the presence of thrombotic events or other coagulopathies, but also high-level inflammation. In contrast, ferritin, an intracellular protein that stores iron, serves as a marker for iron metabolism and inflammation. Abnormal ferritin levels can signify iron overload or deficiency and may be indicative of systemic inflammation or infection.
By assessing these biomarkers, healthcare professionals can uncover latent pathological conditions that might otherwise remain undetected until they progress to more severe stages. This approach allows for timely intervention and the implementation of therapeutic strategies to mitigate potential adverse outcomes.
Such proactive measures are essential in improving the health of general populations, both in diseased subjects and in young individuals during normal daily life and in or involved in sport activities.
What do D-dimer and ferritin levels indicate about the state of the body?
D-dimers
D-dimers are small protein fragments in the blood that are produced when a blood clot is broken down. Elevated D-dimer levels can indicate various medical conditions:
- Thrombosis: An elevated D-dimer level may indicate deep vein thrombosis (DVT) or pulmonary embolism.
- Disseminated intravascular coagulation (DIC): a condition in which blood clots develop throughout the body and excessive bleeding occurs at the same time.
- · Other conditions: acute or chronic inflammation primarily, infections, liver disease, pregnancy, and some cancers can also cause elevated D-dimer levels.
Ferritin
Measuring the level of ferritin in the blood provides information about the body's iron stores. Abnormal ferritin levels can indicate a variety of conditions:
- · Iron deficiency anemia: Low ferritin levels are often a sign of insufficient iron stores, which can lead to anemia.
- · Inflammatory conditions and infections: Ferritin can increase as an indirect sign of acute and/or chronic cell inflammation, both due to an infection and due to a chronic degenerative disease (e.g. autoimmune diseases, diabetes, obesity, cardio-cerebro-cardio-vascular diseases, cancer etc.)
- · Iron overload: High ferritin levels can indicate iron overload, as occurs in hemochromatosis, a genetic disease, for example.
Both D-dimer and ferritin are helpful markers for identifying or ruling out certain disease states, but they should always be interpreted in the context of other clinical findings and tests.
D-dimer reference values
D-dimer reference values can vary depending on the test method used and the laboratory. Generally, a level of less than 0.5 milligram per liter (mg/L) or 500 nanograms per milliliter (ng/mL) is considered normal. Levels above this cut-off may indicate the presence of blood clots or or other medical inflammation-based conditions that require further investigation.
Ferritin reference values
Normal ferritin levels also vary depending on the laboratory, age, and gender. Here are general guidelines:
Men: 20-500 micrograms per liter (µg/L)
Women: 10-200 µg/L
Generally, it is desirable to maintain ferritin level below 100 µg/L, a value which is usually associated to a healthy non-inflammatory condition of human cells.
Low levels may indicate iron deficiency, while high levels may indicate iron overload or inflammation in the body.
Elevated D-dimer and ferritin levels have been observed in most COVID-19 patients. However, these increases are not specific for the presence of the virus' spike proteins, but rather reflect a response by the body to the infection, particularly in the context of inflammatory processes and coagulation disorders:
- Elevated D-dimer levels may indicate increased clotting activity and blood clot breakdown, which is more common in severe COVID-19 cases with complications such as thrombosis.
- Elevated ferritin levels may be interpreted as part of the body's acute inflammatory response to infection.
Nevertheless, these laboratory values are just one aspect of a larger clinical scenario and should be interpreted alongside other clinical data. They are not exclusive to COVID-19 and can also be elevated in various other medical conditions.
Further potential biomarkers could be explored in these patients, focusing on processes related to mitochondria, immunity/inflammation, and histamine. For instance, free radicals, venous lactate, CRP, ESV, IL-6, histamine levels, and immunoglobulins might also be measured.
Treatment
According to COMUSAV doctors, CDS has proven effective not only in combating COVID-19 [link], long COVID [link], and providing protection against the virus and shedding [link], but it has also been notably successful in mitigating damage caused by the mRNA vaccine.
In fact, CDS may exert both direct and indirect effects on spike proteins as an oxidizing agent, and mitigate free radical excess due to its reductive properties, which arise from mitochondrial dysregulation. It can also address histamine hyper-concentration, counteract pro-coagulant states, and more generally, manage hyperinflammatory conditions. The molecule’s versatility and pleiotropic characteristics position it as a prominent initial therapeutic option for patients suffering from adverse effects induced with COVID vaccination.
Using protocol C for oral intake over a period of 3-6 months has alleviated or eliminated symptoms in most cases of COVID-19 related adverse effects.
For more severe situations, protocol E or EC can be added, as well as intravenous protocol Y can be utilized in extremely critical cases like severe autoimmune diseases, markedly disabling neural/muscular or neurodegenerative diseases and in any long-lasting recalcitrant and severe medical case like Guillen Barre. Here's a recovered testimony [Link].
Conclusion
The potential of chlorine dioxide to effectively mitigate damage associated with mRNA vaccines is indeed significant and cannot be overstated. Its remarkable ability to address a wide array of physiological disturbances—such as inflammation, oxidative stress, mitochondrial degeneration, and the dysmetabolism of critical elements like histamine and iron—complemented by its capacity to facilitate rapid cellular changes, underscores the essential role that CDS plays in enhancing vaccine safety. As further research continues to unfold and expand our understanding, CDS hopefully become an indispensable component of post-vaccination care and more. This offers considerable reassurance to individuals who harbor concerns about the long-term safety implications of mRNA vaccines. Moreover, it serves as a vital tool in the mitigation and recovery from potential vaccine-related damage, providing a scientifically backed pathway towards improved health outcomes.
Post Data:
There have been numerous and widespread claims circulating about the presence and use of graphene oxide in the context of mRNA COVID-19 vaccines. These assertions have sparked a variety of discussions and debates, leading to both curiosity and concern among the public and scientific communities. During my time at the Swiss University Bern at theDepartment of Microbiology, specialized in stem cells, I had the opportunity to engage in insightful conversations with my colleagues regarding this topic. They provided a clear and detailed explanation, shedding light on the role of graphene oxide in scientific applications.
According to their expertise, graphene oxide is utilized as a non-chemical transducer. This means it can facilitate the introduction of various substances into cells. One of its remarkable properties is its ability to slightly cut open the cellular membrane, allowing substances to penetrate without altering or disrupting the biochemical values within the cell, unlike other chemical transducers that might cause unwanted alterations in Lab research.
Graphene oxide possesses an acidic pH level, approximately around 1.5, which renders it highly susceptible to oxidation and subsequent destruction. This vulnerability is primarily due to its structure, as it is extraordinarily thin, being only one atom thick. This unique characteristic makes it prone to rapid degradation when exposed to oxidative conditions.
Theoretically, graphene oxide may also function by oxidizing and causing damage to so-called nanobots through a process akin to oxidation or "burning." This potential mechanism adds another layer of complexity and intrigue to the ongoing discussions about its applications and effects.
These insights underscore the importance of continued research and dialogue in understanding the multifaceted roles and impacts of materials like graphene oxide in modern medicine and biotechnology. The ongoing exploration and evaluation of such substances are crucial in advancing our knowledge and ensuring the safe and effective development of innovative medical solutions.
